Tuesday, December 17, 2024
HomeTagsClarity AD study

Clarity AD study

Frontage Partners with Eisai and Biogen to Complete the Clarity AD study

Frontage's Bioanalytical team partnered with Eisai/Biogen to support the PK and PD biomarker bioanalysis of lecanemab (BAN2401) in their investigational global phase 3 study...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics